Therapeutic Area

Fungal Infections

Therapeutic area intelligence for Fungal Infections with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

LIPUS →

Recent signals(2)

ClinicalJune 19, 2026

Study on Genetic Factors in Fungal Infection Susceptibility Launched

A new study aims to investigate immune disorders that increase susceptibility to fungal infections, specifically Candida.

ClinicalJune 10, 2026

LIPUS and microbubbles enhance amphotericin B delivery for cryptococcal meningitis therapy

Low-intensity pulsed ultrasound combined with microbubbles significantly increased BBB permeability, enhancing amphotericin B delivery and efficacy against cryptococcal meningitis in a murine model.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Infectious Disease →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.